Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Impact of MDR1 genetic polymorphisms on postoperative piritramide analgesia

O. Matouskova, O. Slanar, J. Adamkova, P. Pafko, F. Perlik, S. Adamek,

. 2013 ; 114 (3) : 133-5.

Jazyk angličtina Země Slovensko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc13031614

OBJECTIVES: The aim of prospective study was to evaluate the therapeutic efficacy of piritramide in patients after removal of parathyroid glands in relation to MDR1 genotype. In the treatment of moderate acute postoperative pain, piritramide plays a major role. It is difficult to predict its optimal therapeutic efficacy and tolerability in individual patients. METHODS: We compared the effect of piritramide in 56 patients after surgical removal of parathyroid glands in a prospective study. We evaluated pain intensity, pain difference and sum of pain difference (SPID) using visual analogue scale (VAS in mm) and adverse effects in the relationship with the MDR1 - polymorphism of G2677T/A. RESULTS: In the wild-type group (2677GG), there was maximal pain difference of 30.6 ± 24.9 and SPID of 209.33 ± 95.80 while in genotype 2677TT and 2677GT, the corresponding values were 19.5 ± 25.5 and 147.07 ± 91.38, respectively. In group of patients with wild type of 2677GG genotype, there was 80 % of responders with more than 50 % reduction in VAS as compared to baseline while in group with carriers of 2677T allele, there are only 39 % of responders present (χ² = 5. 83; p = 0.016). Furthermore, the total consumption of piritramide was lower in comparison with the variant-allele carrying group (p = 0.008). The total incidence of adverse drug reactions was observed in 40 % of patients with wild type of 2677GG genotype when compared to 83% in the group carrying the variant allele (χ² = 7.92; p = 0.005). Significantly more patients in the wild-type group were satisfied with postoperative pain treatment in comparison to the variant allele group (χ² = 6. 49; p = 0.0109). CONCLUSION: We observed a better analgesic effect of piritramide and a decreased incidence of side effects in the wild-type genotype (2677GG) group, when compared with variant-allele carrying patients (Tab. 2, Fig. 1, Ref. 7).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031614
003      
CZ-PrNML
005      
20171209133502.0
007      
ta
008      
131002s2013 xo f 000 0|eng||
009      
AR
024    7_
$a 10.4149/bll_2013_029 $2 doi
035    __
$a (PubMed)23406179
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Matouskova, O $u Institute of Pharmacology, First Faculty of Medicine, General Teaching Hospital, Charles University in Prague Czech Republic.
245    10
$a Impact of MDR1 genetic polymorphisms on postoperative piritramide analgesia / $c O. Matouskova, O. Slanar, J. Adamkova, P. Pafko, F. Perlik, S. Adamek,
520    9_
$a OBJECTIVES: The aim of prospective study was to evaluate the therapeutic efficacy of piritramide in patients after removal of parathyroid glands in relation to MDR1 genotype. In the treatment of moderate acute postoperative pain, piritramide plays a major role. It is difficult to predict its optimal therapeutic efficacy and tolerability in individual patients. METHODS: We compared the effect of piritramide in 56 patients after surgical removal of parathyroid glands in a prospective study. We evaluated pain intensity, pain difference and sum of pain difference (SPID) using visual analogue scale (VAS in mm) and adverse effects in the relationship with the MDR1 - polymorphism of G2677T/A. RESULTS: In the wild-type group (2677GG), there was maximal pain difference of 30.6 ± 24.9 and SPID of 209.33 ± 95.80 while in genotype 2677TT and 2677GT, the corresponding values were 19.5 ± 25.5 and 147.07 ± 91.38, respectively. In group of patients with wild type of 2677GG genotype, there was 80 % of responders with more than 50 % reduction in VAS as compared to baseline while in group with carriers of 2677T allele, there are only 39 % of responders present (χ² = 5. 83; p = 0.016). Furthermore, the total consumption of piritramide was lower in comparison with the variant-allele carrying group (p = 0.008). The total incidence of adverse drug reactions was observed in 40 % of patients with wild type of 2677GG genotype when compared to 83% in the group carrying the variant allele (χ² = 7.92; p = 0.005). Significantly more patients in the wild-type group were satisfied with postoperative pain treatment in comparison to the variant allele group (χ² = 6. 49; p = 0.0109). CONCLUSION: We observed a better analgesic effect of piritramide and a decreased incidence of side effects in the wild-type genotype (2677GG) group, when compared with variant-allele carrying patients (Tab. 2, Fig. 1, Ref. 7).
650    _2
$a opioidní analgetika $x terapeutické užití $7 D000701
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a P-glykoprotein $x genetika $7 D020168
650    12
$a měření bolesti $7 D010147
650    _2
$a pooperační bolest $x farmakoterapie $7 D010149
650    _2
$a paratyreoidektomie $7 D016105
650    _2
$a pirinitramid $x terapeutické užití $7 D010892
650    12
$a polymorfismus genetický $7 D011110
655    _2
$a časopisecké články $7 D016428
700    1_
$a Slanar, O $u -
700    1_
$a Adamkova, J $u - $7 gn_A_00001436
700    1_
$a Pafko, P $u -
700    1_
$a Perlik, F $u -
700    1_
$a Adámek, Svatopluk $u - $7 mzk2007363535 $4
773    0_
$w MED00000845 $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 114, č. 3 (2013), s. 133-5
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23406179 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20131003104952 $b ABA008
999    __
$a ok $b bmc $g 995701 $s 830059
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 114 $c 3 $d 133-5 $i 0006-9248 $m Bratislavské lekárske listy $n Bratisl Lek Listy $x MED00000845
LZP    __
$a Pubmed-20131002

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...